First Trust SkyBridge Crypto Industry and Digital Economy ETF (ARCA: CRPT)

Dernières nouvelles pour First Trust SkyBridge Crypto Industry and Digital Economy ETF (ARCA:CRPT)

First Trust SkyBridge Crypto Industry and Digital Economy ETF

Technology

Financial Services

Other

Consumer Cyclical

Healthcare

The Fund will invest at least 80% of its net assets (plus any investment borrowings) in the common stocks and American Depositary Receipts (ADRs) of Crypto Industry Companies and Digital Economy Companies. Under normal market conditions, the Fund will invest at least 50% of its net assets (plus any investment borrowings) in Crypto Industry Companies. The remainder of the Funds net assets used to satisfy the 80% test set forth above will be invested in Digital Economy Companies.1. Crypto Industry Companies are those companies that (i) derive at least 50% of their revenue or profits directly from goods produced or sold, investments made, or services performed in the crypto industry ecosystem (defined below); and/or (ii) have at least 50% of their net assets accounted for by direct holdings of bitcoin, ether or another cryptocurrency (collectively, crypto assets). The Funds investment sub-adviser, SkyBridge Capital II, LLC (SkyBridge or the Sub-Advisor), defines crypto industry ecosystem to be those companies involved in servicing the crypto asset markets, including crypto asset mining firms, crypto mining equipment suppliers, crypto asset trading and asset management companies and companies directly holding crypto assets on their balance sheets.2.Digital Economy Companies are those companies that derive at least 50% of their revenue or profits directly from goods produced or sold, investments made, or services performed in the digital economy ecosystem (defined below). The Sub-Advisor defines digital economy ecosystem to be those companies: (i) operating as digital banks with no physical branches, or, operating as banks with physical branches that nonetheless derive the requisite 50% profits or revenues from digital banking; (ii) operating online brokerage or trading platforms and/or conducting digital market making; (iii) operating digital payment gateways or (iv) manufacturing semiconductors. For the avoidance of doubt, companies deemed to be Crypto Industry Companies will not be considered Digital Economy Companies.

Microstrategy Inc

Coinbase Global, Inc.

Galaxy Digital Holdings Ltd.

Marathon Digital Holdings, Inc.

Riot Blockchain Inc.

Iris Energy Ltd.

Cleanspark Inc.

Terawulf Inc

Cipher Mining Inc

Bitdeer Technologies Group

Ishares Bitcoin Trust

Vaneck Bitcoin Trust

Invesco Galaxy Bitcoin ETF

Bitwise Bitcoin Etf

Fidelity Wise Origin Bitcoin F Shs

Nvidia Corp.

Alphabet Inc

Robinhood Markets Inc - A

Metaplanet Inc.

Crypterium - United States Dollar

Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) in comparison to its major competitors within the Semiconductors &amp; Semiconductor Equipment industry. By analyzing critical financial metrics, market position, and growth potential, our objective is to provide valuable insights for investors and offer a deeper understanding of company's performance in the industry.
<h3>NVIDIA Background</h3>
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVIDIA Corp</td>
<td>44.32</td>
<td>39.96</td>
<td>22.88</td>
<td>23.01%</td>
<td>$22.58</td>
<td>$26.67</td>
<td>69.18%</td>
</tr>
<tr>
<td>Broadcom Inc</td>
<td>115.14</td>
<td>16.76</td>
<td>21.99</td>
<td>8.01%</td>
<td>$8.54</td>
<td>$10.14</td>
<td>24.71%</td>
</tr>
<tr>
<td>Taiwan Semiconductor Manufacturing Co Ltd</td>
<td>23.33</td>
<td>6.62</td>
<td>9.61</td>
<td>8.19%</td>
<td>$608.71</td>
<td>$493.4</td>
<td>41.61%</td>
</tr>
<tr>
<td>Advanced Micro Devices Inc</td>
<td>83.67</td>
<td>3.21</td>
<td>6.75</td>
<td>1.23%</td>
<td>$1.59</td>
<td>$3.74</td>
<td>35.9%</td>
</tr>
<tr>
<td>Texas Instruments Inc</td>
<td>34.89</td>
<td>10.20</td>
<td>10.55</td>
<td>7.08%</td>
<td>$1.85</td>
<td>$2.31</td>
<td>11.14%</td>
</tr>
<tr>
<td>Qualcomm Inc</td>
<td>14.96</td>
<td>5.81</td>
<td>3.90</td>
<td>10.3%</td>
<td>$3.67</td>
<td>$6.04</td>
<td>16.93%</td>
</tr>
<tr>
<td>ARM Holdings PLC</td>
<td>168.07</td>
<td>19.52</td>
<td>33.44</td>
<td>3.17%</td>
<td>$0.46</td>
<td>$1.21</td>
<td>33.73%</td>
</tr>
<tr>
<td>Micron Technology Inc</td>
<td>23.49</td>
<td>2.26</td>
<td>3.54</td>
<td>3.32%</td>
<td>$3.95</td>
<td>$2.96</td>
<td>38.27%</td>
</tr>
<tr>
<td>Analog Devices Inc</td>
<td>58.55</td>
<td>3.05</td>
<td>10.94</td>
<td>1.63%</td>
<td>$1.2</td>
<td>$1.61</td>
<td>22.28%</td>
</tr>
<tr>
<td>Monolithic Power Systems Inc</td>
<td>17.84</td>
<td>9.80</td>
<td>13.62</td>
<td>4.17%</td>
<td>$0.18</td>
<td>$0.35</td>
<td>39.24%</td>
</tr>
<tr>
<td>STMicroelectronics NV</td>
<td>21.23</td>
<td>1.26</td>
<td>1.91</td>
<td>0.32%</td>
<td>$0.51</td>
<td>$0.84</td>
<td>-27.36%</td>
</tr>
<tr>
<td>ASE Technology Holding Co Ltd</td>
<td>18.61</td>
<td>1.97</td>
<td>1.02</td>
<td>2.39%</td>
<td>$27.16</td>
<td>$24.89</td>
<td>11.56%</td>
</tr>
<tr>
<td>United Microelectronics Corp</td>
<td>12.37</td>
<td>1.48</td>
<td>2.42</td>
<td>2.06%</td>
<td>$23.86</td>
<td>$15.45</td>
<td>5.91%</td>
</tr>
<tr>
<td>ON Semiconductor Corp</td>
<td>29.54</td>
<td>2.21</td>
<td>2.74</td>
<td>-5.78%</td>
<td>$-0.37</td>
<td>$0.29</td>
<td>-22.39%</td>
</tr>
<tr>
<td>First Solar Inc</td>
<td>12.71</td>
<td>1.96</td>
<td>3.78</td>
<td>2.59%</td>
<td>$0.35</td>
<td>$0.34</td>
<td>6.35%</td>
</tr>
<tr>
<td>Credo Technology Group Holding Ltd</td>
<td>216.03</td>
<td>15.61</td>
<td>25.98</td>
<td>4.95%</td>
<td>$0.03</td>
<td>$0.09</td>
<td>154.44%</td>
</tr>
<tr>
<td>Skyworks Solutions Inc</td>
<td>26.93</td>
<td>1.74</td>
<td>2.81</td>
<td>1.11%</td>
<td>$0.22</td>
<td>$0.39</td>
<td>-8.87%</td>
</tr>
<tr>
<td>Qorvo Inc</td>
<td>131.67</td>
<td>2.09</td>
<td>1.96</td>
<td>0.93%</td>
<td>$0.11</td>
<td>$0.37</td>
<td>-7.6%</td>
</tr>
<tr>
<td>Universal Display Corp</td>
<td>30.45</td>
<td>4.19</td>
<td>10.76</td>
<td>3.93%</td>
<td>$0.08</td>
<td>$0.13</td>
<td>0.62%</td>
</tr>
<tr>
<td>Lattice Semiconductor Corp</td>
<td>121.24</td>
<td>8.71</td>
<td>12.69</td>
<td>0.71%</td>
<td>$0.02</td>
<td>$0.08</td>
<td>-14.68%</td>
</tr>
<tr>
<td>Average</td>
<td>61.09</td>
<td>6.23</td>
<td>9.5</td>
<td>3.17%</td>
<td>$35.9</td>
<td>$29.72</td>
<td>19.04%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By analyzing NVIDIA, we can infer the following trends: 
<ul>
<li>
The Price to Earnings ratio of 44.32 is 0.73x lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
It could be trading at a premium in relation to its book value, as indicated by its Price to Book ratio of 39.96 which exceeds the industry average by 6.41x.
</li>
<li>
With a relatively high Price to Sales ratio of 22.88, which is 2.41x the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
The company has a higher Return on Equity (ROE) of 23.01%, which is 19.84% above the industry average. This suggests efficient use of equity to generate profits and demonstrates profitability and growth potential.
</li>
<li>
The company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $22.58 Billion, which is 0.63x below the industry average. This potentially indicates lower profitability or financial challenges.
</li>
<li>
The gross profit of $26.67 Billion is 0.9x below that of its industry, suggesting potential lower revenue after accounting for production costs.
</li>
<li>
With a revenue growth of 69.18%, which surpasses the industry average of 19.04%, the company is demonstrating robust sales expansion and gaining market share.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748962814_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio provides insights into the proportion of debt a company has in relation to its equity and asset value.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
When comparing NVIDIA with its top 4 peers based on the Debt-to-Equity ratio, the following insights can be observed:
<ul>
<li>
When considering the debt-to-equity ratio, NVIDIA exhibits a stronger financial position compared to its top 4 peers.
</li>
<li>
This indicates that the company has a favorable balance between debt and equity, with a lower debt-to-equity ratio of 0.12, which can be perceived as a positive aspect by investors.
</li>
</ul>
<h3>Key Takeaways</h3>
For NVIDIA, the PE ratio is low compared to peers, indicating potential undervaluation. The high PB and PS ratios suggest strong market sentiment and revenue multiples. The high ROE reflects efficient use of shareholder funds, while low EBITDA and gross profit may indicate operational challenges. The high revenue growth signifies strong top-line performance relative to industry peers in the Semiconductors &amp; Semiconductor Equipment sector.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Markets

Trading Ideas

NVDA

Understanding NVIDIA's Position In Semiconductors &amp; Semiconductor Equipment Industry Compared To Competitors

<a href="https://www.dailymail.co.uk/health/article-14773791/ozempic-weight-loss-drugs-kidney-cancer-risk-study.html" title="https://www.dailymail.co.uk/health/article-14773791/ozempic-weight-loss-drugs-kidney-cancer-risk-study.html">https://www.dailymail.co.uk/health/article-14773791/ozempic-weight-loss-drugs-kidney-cancer-risk-study.html</a>

Biotech

General

"Exclusive: Ozempic Linked To 'Silent Cancer' That Is Rising In Young People As Doctors Issue Shock Warning" - DailyMail+

WIIM

ERNA

Ernexa Therapeutics shares are trading lower after the company announced it will increased the authorized shares of common stock from 100 million to 150 million shares.

<a href="https://www.bloomberg.com/news/articles/2025-06-03/china-s-nio-to-reduce-r-d-costs-to-hit-break-even-goal?srnd=homepage-americas&amp;embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-03/china-s-nio-to-reduce-r-d-costs-to-hit-break-even-goal?srnd=homepage-americas&amp;embedded-checkout=true</a>

'Chinese EV Maker Nio to Reduce R&D Costs to Hit Break-Even Goal'- Bloomberg

Telsey Advisory Group analyst Dana Telsey maintains Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) with a Market Perform and maintains $62 price target.

Price Target

Analyst Ratings

Telsey Advisory Group Maintains Market Perform on Signet Jewelers, Maintains $62 Price Target

Student loan debt in the United States has reached unprecedented levels, with borrowers collectively owing more than $1.77 trillion as of 2025, according to the Education Data Initiative.&nbsp;
As tuition costs continue to rise, many graduates struggle to manage monthly payments which can lead to challenges including delinquency, default and<a href="https://www.benzinga.com/personal-finance/management/25/06/45739976/trump-administration-pauses-social-security-garnishments-over-defaulted-student-loans-department-will-begin-proactive-outreach-to-recipients"> long-term financial insecurity.&nbsp;</a>
One TikTok-er has a "solution."&nbsp;
Read Next: <a href="https://www.benzinga.com/news/space/25/06/45724938/space-stocks-weekly-countdown-rocketlab-gets-analyst-love-while-virgin-galactic-slides-into-june?utm_source=articleShare">Space Stocks Weekly Countdown: RocketLab Gets Analyst Love While Virgin Galactic Slides Into June</a>
The Details: TikTok user @thenormajeane5 recently went viral with <a href="https://www.tiktok.com/@thenormajeane5/video/7509221877844446510?lang=en">a post</a> detailing his unconventional strategy: staying in school indefinitely to keep student loans in deferment and avoid repayment.&nbsp;
<figure class="wp-block-embed is-type-video is-provider-tiktok wp-block-embed-tiktok"> 
<div class="wp-block-embed__wrapper">
<blockquote class="tiktok-embed" cite="https://www.tiktok.com/@thenormajeane5/video/7509221877844446510" data-video-id="7509221877844446510" data-embed-from="oembed" style="max-width:605px; min-width:325px;"> <section> <a target="_blank" title="@thenormajeane5" href="https://www.tiktok.com/@thenormajeane5?refer=embed">@thenormajeane5</a>
For legal purporses this is SATIRE: I'm never going to pay back those student loans. &#8211; don't get me wrong I know it's inevitable and I hope to be in a better place in the future I guess. 
 <a target="_blank" title="♬ Don't Forget About Us - KAYTRANADA Remix - Mariah Carey &#038; KAYTRANADA" href="https://www.tiktok.com/music/Don't-Forget-About-Us-KAYTRANADA-Remix-7489248146356586512?refer=embed">♬ Don&#8217;t Forget About Us &#8211; KAYTRANADA Remix &#8211; Mariah Carey &#038; KAYTRANADA</a> </section> </blockquote>
<script async src="https://www.tiktok.com/embed.js"></script></div>
</figure>
Thenormajeane5, who is currently working toward a doctoral degree, explained that after graduating in about two and a half years, he plans to keep pursuing associate degrees for the rest of his life in order to remain a lifelong student and postpone repayment indefinitely.&nbsp;
The creative approach resonated with thousands online, racking up nearly 500,000 likes and more than 11,000&nbsp; comments.&nbsp;
Many viewers shared similar stories. One commenter said their professor had over $800,000 in student loans and was still enrolled, joking that he'd never pay it back. Another mentioned their grandmother, who kept enrolling in new degrees and was about to graduate with her master's degree.&nbsp;
Others described using employer tuition reimbursement programs to keep taking classes, or simply repeating the deferment strategy for years.&nbsp;
Read Next: <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45727360/amazon-analyst-sees-robotics-unlocking-billions-in-savings?utm_source=articleShare">Amazon Analyst Sees Robotics Unlocking Billions In Savings</a>
Other Options: Student loan borrowers have other, perhaps more financially responsible options, including income-driven repayment plans and student loan refinancing.&nbsp;
Borrowers struggling to repay federal student loans can apply for an <a href="https://studentaid.gov/manage-loans/repayment/plans/income-driven#:~:text=An%20income%2Ddriven,0%20per%20month.">income-driven repayment</a> plan which bases monthly student loan payment amounts on income and family size. For some people, payments on an IDR plan can be as low as $0 per month.
Borrowers with private student loans have other options like refinancing in order to achieve lower monthly payments. SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) specializes in student loan refinancing and Citizens Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>) offers student loan refinancing through Citizens Bank.&nbsp;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/management/25/05/45675714/can-michael-burrys-nvidia-short-survive-the-stocks-stunning-comeback?utm_source=articleShare">Can Michael Burry&#8217;s Nvidia Short Survive The Stock&#8217;s Stunning Comeback?</a></li>
</ul>
Image: Shutterstock

Social Media

Personal Finance

SOFI

The Viral Student Loan Solution People Can't Stop Talking About

Stifel analyst Matthew Smith maintains The Campbell's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) with a Hold and lowers the price target from $40 to $38.

Stifel Maintains Hold on The Campbell's, Lowers Price Target to $38

Telsey Advisory Group analyst Cristina Fernandez maintains Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) with a Outperform and maintains $60 price target.

Telsey Advisory Group Maintains Outperform on Academy Sports, Maintains $60 Price Target

Stifel analyst Selman Akyol maintains Kinder Morgan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>) with a Hold and raises the price target from $27 to $28.

Stifel Maintains Hold on Kinder Morgan, Raises Price Target to $28

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) may be setting up for a massive rally if its long-term logarithmic growth channel holds, according <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">to traders&#8217; analysis.</a>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1949</td>
<td>$29.2 billion</td>
<td>+2.7%&nbsp;</td>
<td>-14.9%&nbsp;</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001315</td>
<td>$7.8 billion</td>
<td>+2.9%&nbsp;</td>
<td>-9.5%&nbsp;</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>&nbsp;$0.00001260</td>
<td>$5.3 billion</td>
<td>+8.9%&nbsp;</td>
<td>-10.2%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: On June 3, crypto analyst Kevin highlighted a key support zone between $0.1839 and $0.1901 as a launchpad for the next leg higher.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Come on <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> show us what your made of &#x1f91d; <a href="https://t.co/5omq3H4ppQ">https://t.co/5omq3H4ppQ</a> <a href="https://t.co/ndgJ7Ms1vc">pic.twitter.com/ndgJ7Ms1vc</a>
&mdash; Kevin (@Kev_Capital_TA) <a href="https://twitter.com/Kev_Capital_TA/status/1929711717069758638?ref_src=twsrc%5Etfw">June 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto Tony <a href="https://x.com/CryptoTony__/status/1929863383601332651">remains</a> long from $0.148, expecting a breakout above $0.248 to confirm the next move. 
Trader Tardigrade pointed to Dogecoin's 3-day RSI hovering around 50, a level that has historically preceded major rallies, with upside potential toward $1.
Meanwhile, Bitcoinsensus <a href="https://x.com/Bitcoinsensus/status/1929469386957713620">identified</a> that DOGE has been respecting a logarithmic channel since 2014. 
Past performances include: a 10x from 2014 to 2017 and a 37x from 2017 to 2021. 
This could lead to a possible 21x from 2021 to a projected 2025 peak.
If this pattern plays out, DOGE could reach up to $16, an extraordinary gain backed by a decade of price action rather than just short-term hype.
Statistics: On May 31, Whale Alert <a href="https://x.com/whale_alert/status/1928867003378397425">reported</a> a 104.13 million DOGE transfer, worth around $20 million, to Coinbase on May 31, sparking some concerns over potential sell pressure.
Coinglass data shows Dogecoin liquidations in the past 24 hours at $3.6 million, with $2.39 million in short liquidations. Open interest in a single day spiked 3.2% while DOGE derivatives trading volume expanded by 12.4%. Options volume is up by 185%.
Community News: On June 1, Dogecoin Foundation's senior software engineer Ed Tubbs <a href="https://x.com/EdTubbs/status/1929236466166558746">announced</a> the release of libdogecoin v0.1.4, which introduces Trusted Execution Environment (TEE) for secure key management and signatures.
With this upgrade, Dogecoin becomes one of the first cryptocurrencies to support TEE, a feature designed to enhance wallet security in the face of rising threats across the crypto ecosystem.
Currently, DOGE boasts $1.06 billion in trading volume, reflecting growing market interest.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45624852/dogecoins-chart-screams-caution-as-bulls-get-rejected-again">Dogecoin&#8217;s Chart Screams Caution As Bulls Get Rejected Again</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Dogecoin Could Explode For A 2,100% Gain If This Pattern Holds, Trader Warns

Effective June 2, 2025, Ernexa Therapeutics Inc. (the &quot;Company&quot;), filed a certificate of amendment to the Company&#39;s Restated Certificate of Incorporation, as amended (the &quot;Amended COI&quot;) with the Secretary of State of Delaware to increase the authorized shares of its common stock from 100,000,000 to 150,000,000.
&nbsp;
Additionally, effectively June 2, 2025, the Company filed a certificate of amendment to its Amended COI with the Secretary of State of Delaware to allow for action required or permitted to be taken by stockholders of the Company to be effected by written consent of such stockholders in addition to duly called annual or special meetings of such stockholders.

Reported June 2, 2025: Ernexa Therapeutics Amends Certificate Of Incorporation To Increase Authorized Common Stock From 100M To 150M Shares

New long-term CARTITUDE-1 data show one-third of patients treated with CARVYKTI&#xAE;&nbsp;remain progression-free
CARTITUDE-4 analysis shows compelling overall survival and progression-free benefits in standard and high-risk subgroups across prior lines of treatment
CHICAGO, June 3, 2025 /PRNewswire/ --&nbsp;Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) announced today new long-term follow-up data from the Phase 1b/2 CARTITUDE-1 study demonstrating 33 percent (n=32) of patients in the study (n=97) with relapsed or refractory multiple myeloma (RRMM) treated with CARVYKTI&#xAE; (ciltacabtagene autoleucel; cilta-cel) achieved progression-free survival (PFS) of five years or more with a single infusion and no maintenance or subsequent anti-myeloma therapy.1 These data underscore Johnson &amp; Johnson's dedication to advancing transformative therapies that aim to reshape the treatment landscape for patients with multiple myeloma.
In a subset of 12 patients who underwent serial evaluations at a single site, all were minimal residual disease (MRD) negative and imaging negative throughout five years of post-treatment follow-up. Findings were featured in an oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract #7507). The data were also simultaneously published in The Journal of Clinical Oncology.

Johnson & Johnson Says New Long-Term CARTITUDE-1 Data Show One-Third Of Patients Treated With CARVYKTI Remain Progression-Free

Stifel analyst Tore Svanberg maintains Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) with a Buy and raises the price target from $69 to $80.

CRDO

Stifel Maintains Buy on Credo Technology Group, Raises Price Target to $80

Telsey Advisory Group analyst Dana Telsey maintains Designer Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>) with a Market Perform and maintains $5 price target.

Telsey Advisory Group Maintains Market Perform on Designer Brands, Maintains $5 Price Target

More than half of patients maintained minimal residual disease (MRD) negativity (10-5) with DARZALEX FASPRO&#xAE;&nbsp;for 24 months or longer in the Phase 3 PERSEUS study
Data from Phase 3 CEPHEUS study show 60 percent overall MRD negativity (10−5) and improved PFS with DARZALEX FASPRO&#xAE; in transplant-ineligible newly diagnosed patients
CHICAGO, June 3, 2025 /PRNewswire/ -- Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) today announced data from two studies highlighting that a DARZALEX FASPRO&#xAE; (daratumumab and hyaluronidase-fihj)-based quadruplet regimen demonstrated deep and sustained minimal residual disease (MRD) negativity rates, and improved long-term progression-free survival (PFS) in patients with newly diagnosed multiple myeloma (NDMM), regardless of transplant status.1,2,3 Findings were highlighted as oral presentations of an analysis of sustained MRD in transplant-eligible patients from the Phase 3 PERSEUS study (Abstract #7501) and a subgroup analysis of transplant-ineligible patients in the Phase 3 CEPHEUS study (Abstract #7516) at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

Johnson & Johnson Announces Data From Two Studies Highlighting That DARZALEX FASPRO-Based Quadruplet Regimen Demonstrated Deep And Sustained MRD Negativity Rates, And Improved Long-Term PFS In NDMM Patients

Rumors

CURI

Watching CuriosityStream; Traders Circulate Zacks Under $10 Newsletter Picks Stock

VUZI

Wyr.ai Partners With Vuzix On Launch Of M400 Smart Glasses-Based AI Quality Assurance Inspection Platform; Terms Not Disclosed

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLA#NASDAQ">ESLA</a>) with a Buy and maintains $16 price target.

ESLA

D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

Phase 1 trial demonstrates encouraging clinical activity of investigational&nbsp;immunotherapy for relapsed or refractory multiple myeloma
Novel investigational dual-antigen-targeting&nbsp;immunotherapy binds to B-cell maturation antigen (BCMA) and GPRC5D on myeloma cells, as well as CD3 on T-cells&nbsp;
CHICAGO, June 3, 2025 /PRNewswire/ -- Johnson &amp; Johnson announced today initial Phase 1 results of JNJ-79635322 (JNJ-5322), a novel investigational trispecific antibody (TsAb) in patients with relapsed or refractory multiple myeloma. Among the 36 patients who received the recommended phase 2 dose (RP2D), the overall response rate (ORR) was 86.1 percent. In the 27 patients who were naive to BCMA and GPRC5D directed therapies, the ORR was 100 percent at the RP2D. Findings were featured in an oral presentation at the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4439656-1&amp;h=1437573614&amp;u=https%3A%2F%2Fmeetings.asco.org%2Fmeetings%2F2025-asco-annual-%2520meeting%2F327%2Fprogram-guide%2Fscheduled-sessions&amp;a=2025+American+Society+of+Clinical+Oncology+(ASCO)+Annual+Meeting">2025 American Society of Clinical Oncology (ASCO) Annual Meeting</a> (Abstract #<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4439656-1&amp;h=2239716214&amp;u=https%3A%2F%2Fwww.asco.org%2Fabstracts-presentations%2FABSTRACT489908&amp;a=7505">7505</a>). The study will also be featured as one of the six best abstracts during the Plenary Abstracts Session at the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4439656-1&amp;h=2405979170&amp;u=https%3A%2F%2Fehaweb.org%2Fcongress%2Feha2025-congress%2F&amp;a=2025+European+Hematology+Association+(EHA)+Congress">2025 European Hematology Association (EHA) Congress</a> (Abstract #<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4439656-1&amp;h=3428041764&amp;u=https%3A%2F%2Flibrary.ehaweb.org%2Feha%2F2025%2Feha2025-congress%2F4159177%2Frakesh.popat.first-in-human.study.of.jnj-79635322.28jnj-532229.a.novel.html%3Ff%3Dmenu%253D6%252Abrowseby%253D8%252Asortby%253D2%252Amedia%253D3%252Ace_id%253D2882%252Amarker%253D5848%252Afeatured%253D19595&amp;a=S100">S100</a>).

Johnson & Johnson Announces Initial Phase 1 Results Of JNJ-79635322, Investigational TsAb In Patients With Relapsed Or Refractory Multiple Myeloma

ENTA

Enanta Pharmaceuticals shares are trading higher after JMP Securities maintained an Outperform rating on the stock and raised its price target from $23 to $24.

Comments

First Trust SkyBridge Crypto Industry and Digital Economy ETF

Actualités

Dernières nouvelles pour First Trust SkyBridge Crypto Industry and Digital Economy ETF (ARCA:CRPT)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL